As an industry expert, was invited by IMC to join Advisory colleagues to discuss Drug Plan management and the impact to our private payor clients.
Invited to attend a Virtual Policy forum with various industry experts (Insurers, Pharmacist, Pharma, etc) to discuss the implications and challenges for the future of National Pharmacare on October 20, 2020.
Disability incidence rates have increased continually over the past 5 years. This incidence trend, which is the rate at which new claims are changing compared to the past, is industry wide and affects everyone. Based on published reports from industry leaders, Manulife and Sun Life, current Long-Term Disability (LTD) pricing, is not reflective of this [...]
Authors: Patrick Galizia Ione Deda Alves Canada | Publication | September 4, 2020 - 12 PM ET With the end of the Canada Emergency Response Benefit (CERB) fast approaching, the federal government announced on August 20 a number of major changes to the Employment Insurance (EI) program, including the creation of three new economic recovery benefits. In [...]
Today, the Ontario government issued a regulation extending the infectious disease leave available under the Ontario Employment Standards Act, 2000 (“ESA”) until January 2, 2021. What does this mean for employers? In summary, from March 1, 2020 to January 2, 2021: A non-unionized employee whose employer has temporarily reduced or eliminated their hours of work [...]
